{"organizations": [], "uuid": "6d38deac6d187d9e0fe33a76085e58a3885bb25c", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-novartis-ag-ceo-says-believes-avex/brief-novartis-ag-ceo-says-believes-avexis-sma-medicine-has-multi-billion-dollar-peak-sales-potential-idUSFWN1RL04O", "country": "US", "domain_rank": 408, "title": "BRIEF-Novartis AG CEO Says Believes Avexis SMA Medicine Has Multi-Billion Dollar Peak Sales Potential", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-09T09:43:00.000+03:00", "replies_count": 0, "uuid": "6d38deac6d187d9e0fe33a76085e58a3885bb25c"}, "author": "", "url": "https://www.reuters.com/article/brief-novartis-ag-ceo-says-believes-avex/brief-novartis-ag-ceo-says-believes-avexis-sma-medicine-has-multi-billion-dollar-peak-sales-potential-idUSFWN1RL04O", "ord_in_thread": 0, "title": "BRIEF-Novartis AG CEO Says Believes Avexis SMA Medicine Has Multi-Billion Dollar Peak Sales Potential", "locations": [], "entities": {"persons": [{"name": "john miller", "sentiment": "none"}], "locations": [], "organizations": [{"name": "brief-novartis ag", "sentiment": "negative"}, {"name": "has multi-billion dollar peak sales potential reuters", "sentiment": "none"}, {"name": "novartis ag", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 9, 2018 / 6:44 AM / Updated an hour ago BRIEF-Novartis AG CEO Says Believes Avexis SMA Medicine Has Multi-Billion Dollar Peak Sales Potential Reuters Staff 1 Min Read \nApril 9 (Reuters) - Novartis Ag: \n* CEO SAYS PLANS TO USE PORTION OF GSK CONSUMER JOINT VENTURE TRANSACTION PROCEEDS TO BUY AVEXIS \n* CEO SAYS BELIEVES AVEXIS MAIN SMA MEDICINE HAS MULTI-BILLION DOLLAR PEAK SALES POTENTIAL Source text for Eikon: Further company coverage: (Reporting by John Miller)", "external_links": [], "published": "2018-04-09T09:43:00.000+03:00", "crawled": "2018-04-09T10:54:39.003+03:00", "highlightTitle": ""}